Universal Health Services, Inc.
NYSE:UHSMedical - Care Facilities
-$5.64 today
- Market cap
- $9.38B
- Beta
- 1.08
- P/E (TTM)
- 5.7
- EPS (TTM)
- $24.90
- Dividend yield
- 0.57%
Volume 0.67M
Average 0.94M
UHS Selling, General & Admin
Overhead costs of running the business, including sales, marketing, management, and administrative staff.
Universal Health Services, Inc.NYSE: UHS
Selling, General & Admin · Q2 FY2026 · quarter ended Jun 2026
Selling, general & admin grows, but more slowly than its trailing trend
Q2 FY2026 selling, general & admin of $2.14B rose 4.4% year over year, behind the +6.7% change in trailing-twelve-month selling, general & admin. Sequentially, it rose 0.7% from the prior quarter. Over 3 fiscal years it compounded at +6.1% a year.
Context
- Selling, general & admin amounted to 47.4% of revenue in FY2025, down 1.0 pp from a year earlier.
- Selling, general & admin increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether selling, general & admin reaches the consensus estimate from 14 analysts of $9.22B (+12.0%) for the fiscal year ending Dec 2026, a step up from the +7.4% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $2.14B+0.7% QoQ
- Last fiscal yearDec 2025
- $8.23B+7.4% YoY
- LTMJun 2026
- $8.46B+6.7% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +4.4% | +10.6% | +6.2 pp |
| 1 year | +7.4% | +12.0% | +4.6 pp |
| 3-year CAGR | +6.1% | +6.9% | +0.9 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Selling, General & Admin history
USD · from the income statement
- Latest · FY2025
- 8.23B USD
- Year-over-year change
- +7.4%
- 4-year CAGR
- +7.0%
| Period | Period end | Selling, General & Admin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 8.23B | +7.4% |
| FY2024 | 2024-12-31 | 7.67B | +5.7% |
| FY2023 | 2023-12-31 | 7.25B | +5.1% |
| FY2022 | 2022-12-31 | 6.89B | +9.7% |
| FY2021 | 2021-12-31 | 6.28B | — |
Selling, General & Admin vs competitors
How UHS compares with its peers on the latest reported figures
- Peers report in different currencies, so selling, general & admin is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +6.7% is the 4th highest of 9, against a peer median of -5.8%.
- Selling, general & admin amounts to 46.7% of revenue for UHS, versus a peer median of 19.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $16.57B USD | -47.6% | -33.9% | 21.2% | |
| LTM Mar 2026 | $10.62B USD | +3576.1% | — | 49.5% | |
| LTM Jun 2026 | $8.46B USD | +6.7% | +6.1% | 46.7% | |
| LTM Jun 2026 | $6.61B USD | +37.6% | +176.5% | 30.3% | |
| LTM Jun 2026 | €2.98B EUR | -5.2% | -1.5% | 15.3% | |
ARDTArdent Health Partners, LLC | LTM Mar 2026 | $2.06B USD | -42.1% | -29.3% | 32.0% |
| LTM Jun 2026 | $440.8M USD | +7.2% | +5.2% | 17.0% | |
| LTM Sep 2026 | $215.95M USD | -86.3% | -50.3% | 6.3% | |
| LTM Mar 2026 | $56M USD | -6.5% | +103.5% | 6.4% | |
| Peer median (excluding UHS) | — | -5.8% | -1.5% | 19.1% | |
Competitors are the stored peer set for UHS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 12.64B | 13.4B | 14.28B | 15.83B | 17.36B |
| Cost of Revenue | 1.43B | 1.47B | 1.53B | 1.59B | 1.66B |
| Gross Profit | 11.21B | 11.93B | 12.75B | 14.24B | 15.71B |
| Gross Margin | 88.7% | 89.0% | 89.3% | 90.0% | 90.4% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 6.28B | 6.89B | 7.25B | 7.67B | 8.23B |
| Operating Expenses | 9.85B | 10.92B | 11.57B | 12.56B | 13.71B |
| Depreciation & Amortization | 533.21M | 581.86M | 568.04M | 584.83M | 618.74M |
| EBITDA | 1.91B | 1.58B | 1.72B | 2.27B | 2.74B |
| EBITDA Margin | 15.1% | 11.8% | 12.0% | 14.3% | 15.8% |
| Operating Income | 1.36B | 1B | 1.18B | 1.68B | 1.99B |
| Operating Margin | 10.8% | 7.5% | 8.2% | 10.6% | 11.5% |
| Interest Income | 1.6M | 378K | 572K | 1.43M | 1.19M |
| Interest Expense | 85.27M | 127.27M | 207.25M | 187.53M | 157.26M |
| Other Income / Expenses | (69.78M) | (137.3M) | (234.96M) | (183.88M) | (21.87M) |
| Income Before Tax | 1.29B | 866.26M | 940.43M | 1.5B | 1.97B |
| Pre-Tax Margin | 10.2% | 6.5% | 6.6% | 9.5% | 11.4% |
| Income Tax Expense | 305.68M | 209.28M | 221.12M | 334.83M | 460.96M |
| Net Income | 991.59M | 675.61M | 717.8M | 1.14B | 1.49B |
| Net Margin | 7.8% | 5.0% | 5.0% | 7.2% | 8.6% |
| EPS (Basic) | 11.99 | 9.23 | 10.35 | 17.16 | 23.42 |
| EPS (Diluted) | 11.82 | 9.14 | 10.23 | 16.82 | 23.10 |
| Weighted Avg Shares | 82.52M | 73.12M | 69.32M | 66.55M | 63.58M |
| Weighted Avg Shares (Diluted) | 83.69M | 73.83M | 70.13M | 67.9M | 64.46M |
Universal Health Services, Inc.
NYSE:UHS
Intrinsic Alpha fair value
Locked
Current Price
$186.07
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.